Tagged with B

France Genethon, a laboratory created by the patient organization AFM-Telethon, is one of the world’s leaders in the development of biotherapies for rare diseases. In this interview Genethon’s CEO Frédéric Revah explains its role in the discovery of innovative therapies since the 1990s and the recent launch of YposKesi, its innovative…

France Philippe Lamoureux, director of LEEM, the pharmaceutical industry’s association in France, reflects on the winds of change in the sector after the establishment of the Macron government, the 2018 Strategic Council of Health Industries (CSIS) and new pro-industry measures. I believe that we can make France a worldwide leader in…

France Jacques Vernin, president of FACOPHAR Santé – the French association representing companies involved in the natural and herbal health space, explains its role and the future of the organization in participating in social dialogue, shaping regulations and promoting French excellence in the field of herbal ingredients.   Could you please…

Turkey Elif Çelik, executive vice president of the Healthcare Division of Eczacıbaşı Group, explains the rationale behind the group’s divestment of its generics arm and its new strategy to establish itself as a holistic healthcare organization, focused on bringing innovative solutions to Turkey through diverse partnership opportunities. Çelik also discusses the…

Algeria Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria tell us why. As geographically the largest country in Africa, Algeria stands out, as does its universal healthcare system which bears…

China In 2013, Chinese President Xi Jinping launched the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative, corralling the two Special Administrative Regions (SARs) of Hong Kong and Macao with Guangdong, one of the richest of China’s 34 provinces. While the official government blueprint was due to be unveiled in mid-2018, escalating…

UK Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on trading regulations during this time of Brexit uncertainty. “If a transition deal does not make clear what will happen in the future, we will maintain our decision not to invest,” Leif…

Cannabis The opioid epidemic has reached new heights of late, claiming an estimated 40,000 American lives every year. The highly addictive nature of opium-derived medicine is the cause of the rising number of overdoses in the US and Canada. There are companies out there that are working to manufacture a new…

Pharma Legal Handbook Structured legal guide to cannabinoid drugs, medicinal cannabis and opioid drugs in South Africa. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   CANNABINOID DRUGS 1. Are Cannabinoid Drugs authorized in…

Pharma Legal Handbook Regulatory reforms in South African Pharma – a comprehensive legal overview. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. Are there proposals for reform or significant change to the…

Pharma Legal Handbook The ins and outs of patents and trademarks in South African Pharma. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What are the basic requirements to obtain patent and…

Pharma Legal Handbook The key facts about product liability in South African Pharma. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What types of liability are recognized in your jurisdiction? In…